|
Neoplasia
Citations 11-20 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
- David C. Johnson, Sophie Corthals, Christine Ramos, Antje Hoering, Kim Cocks, Nicholas J. Dickens, Jeff Haessler, Harmut Goldschmidt, J. Anthony Child, Sue E. Bell, Graham Jackson, Dalsu Baris, S. Vincent Rajkumar, Faith E. Davies, Brian G. M. Durie, John Crowley, Pieter Sonneveld, Brian Van Ness, and Gareth J. Morgan
Blood 2008; 112: 4924-4934.
[Abstract]
[Full text]
[PDF]
Angiostatic activity of the antitumor cytokine interleukin-21
- Karolien Castermans, Sebastien P. Tabruyn, Rong Zeng, Judy R. van Beijnum, Cheryl Eppolito, Warren J. Leonard, Protul A. Shrikant, and Arjan W. Griffioen
Blood 2008; 112: 4940-4947.
[Abstract]
[Full text]
[PDF]
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- Erik A. Nelson, Sarah R. Walker, Alicia Kepich, Laurie B. Gashin, Teru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, Kenneth C. Anderson, and David A. Frank
Blood 2008; 112: 5095-5102.
[Abstract]
[Full text]
[PDF]
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor–CD3 expression in enteropathy-associated T-cell lymphoma
- Jennifer M. L. Tjon, Wieke H. M. Verbeek, Yvonne M. C. Kooy-Winkelaar, Binh H. Nguyen, Arno R. van der Slik, Allan Thompson, Mirjam H. M. Heemskerk, Marco W. J. Schreurs, Liesbeth H. A. Dekking, Chris J. Mulder, Jeroen van Bergen, and Frits Koning
Blood 2008; 112: 5103-5110.
[Abstract]
[Full text]
[PDF]
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia
- Sophia Adamia, Amanda A. Reichert, Hemalatha Kuppusamy, Jitra Kriangkum, Anirban Ghosh, Jennifer J. Hodges, Patrick M. Pilarski, Steven P. Treon, Michael J. Mant, Tony Reiman, Andrew R. Belch, and Linda M. Pilarski
Blood 2008; 112: 5111-5121.
[Abstract]
[Full text]
[PDF]
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA
- Charles C. Chu, Rosa Catera, Katerina Hatzi, Xiao-Jie Yan, Lu Zhang, Xiao Bo Wang, Henry M. Fales, Steven L. Allen, Jonathan E. Kolitz, Kanti R. Rai, and Nicholas Chiorazzi
Blood 2008; 112: 5122-5129.
[Abstract]
[Full text]
[PDF]
ASB2 targets filamins A and B to proteasomal degradation
- Mélina L. Heuzé, Isabelle Lamsoul, Massimiliano Baldassarre, Yatish Lad, Sophie Lévêque, Ziba Razinia, Christel Moog-Lutz, David A. Calderwood, and Pierre G. Lutz
Blood 2008; 112: 5130-5140.
[Abstract]
[Full text]
[PDF]
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
- Lindsay M. Morton, Sophia S. Wang, Wendy Cozen, Martha S. Linet, Nilanjan Chatterjee, Scott Davis, Richard K. Severson, Joanne S. Colt, Mohammad A. Vasef, Nathaniel Rothman, Aaron Blair, Leslie Bernstein, Amanda J. Cross, Anneclaire J. De Roos, Eric A. Engels, David W. Hein, Deirdre A. Hill, Linda E. Kelemen, Unhee Lim, Charles F. Lynch, Maryjean Schenk, Sholom Wacholder, Mary H. Ward, Shelia Hoar Zahm, Stephen J. Chanock, James R. Cerhan, and Patricia Hartge
Blood 2008; 112: 5150-5160.
[Abstract]
[Full text]
[PDF]
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells
- Ellen Weisberg, Johannes Roesel, Guido Bold, Pascal Furet, Jingrui Jiang, Jan Cools, Renee D. Wright, Erik Nelson, Rosemary Barrett, Arghya Ray, Daisy Moreno, Elizabeth Hall-Meyers, Richard Stone, Ilene Galinsky, Edward Fox, Gary Gilliland, John F. Daley, Suzan Lazo-Kallanian, Andrew L. Kung, and James D. Griffin
Blood 2008; 112: 5161-5170.
[Abstract]
[Full text]
[PDF]
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
- Pascal Gelebart, Mona Anand, Hanan Armanious, Anthea C. Peters, Jennifer Dien Bard, Hesham M. Amin, and Raymond Lai
Blood 2008; 112: 5171-5179.
[Abstract]
[Full text]
[PDF]
|
|
